Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 2, no: 9 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4HKN5
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009451 | RNA modification | 5 | 1 |
GO:0009892 | negative regulation of metabolic process | 4 | 1 |
GO:0009893 | positive regulation of metabolic process | 4 | 1 |
GO:0009894 | regulation of catabolic process | 4 | 1 |
GO:0009895 | negative regulation of catabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010468 | regulation of gene expression | 5 | 1 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 1 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 1 |
GO:0010608 | post-transcriptional regulation of gene expression | 6 | 1 |
GO:0010628 | positive regulation of gene expression | 6 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016553 | base conversion or substitution editing | 6 | 1 |
GO:0016554 | cytidine to uridine editing | 7 | 1 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 1 |
GO:0019222 | regulation of metabolic process | 3 | 1 |
GO:0031323 | regulation of cellular metabolic process | 4 | 1 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 1 |
GO:0031329 | regulation of cellular catabolic process | 5 | 1 |
GO:0031330 | negative regulation of cellular catabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0043487 | regulation of RNA stability | 3 | 1 |
GO:0043488 | regulation of mRNA stability | 4 | 1 |
GO:0043489 | RNA stabilization | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0048255 | mRNA stabilization | 5 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048519 | negative regulation of biological process | 3 | 1 |
GO:0048523 | negative regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 1 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 1 |
GO:0051252 | regulation of RNA metabolic process | 5 | 1 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 1 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 1 |
GO:0061013 | regulation of mRNA catabolic process | 6 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0065008 | regulation of biological quality | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0080090 | regulation of primary metabolic process | 4 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1902369 | negative regulation of RNA catabolic process | 7 | 1 |
GO:1902373 | negative regulation of mRNA catabolic process | 7 | 1 |
GO:1903311 | regulation of mRNA metabolic process | 6 | 1 |
GO:1903312 | negative regulation of mRNA metabolic process | 7 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003723 | RNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016787 | hydrolase activity | 2 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 8 | 12 | PF00656 | 0.731 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.397 |
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.336 |
CLV_NRD_NRD_1 | 89 | 91 | PF00675 | 0.354 |
CLV_PCSK_KEX2_1 | 173 | 175 | PF00082 | 0.398 |
CLV_PCSK_KEX2_1 | 200 | 202 | PF00082 | 0.336 |
CLV_PCSK_SKI1_1 | 147 | 151 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.464 |
CLV_PCSK_SKI1_1 | 90 | 94 | PF00082 | 0.365 |
DEG_APCC_DBOX_1 | 57 | 65 | PF00400 | 0.540 |
DOC_CKS1_1 | 52 | 57 | PF01111 | 0.586 |
DOC_CYCLIN_yCln2_LP_2 | 115 | 121 | PF00134 | 0.302 |
DOC_MAPK_DCC_7 | 207 | 216 | PF00069 | 0.374 |
DOC_MAPK_gen_1 | 104 | 113 | PF00069 | 0.362 |
DOC_MAPK_HePTP_8 | 103 | 115 | PF00069 | 0.278 |
DOC_MAPK_MEF2A_6 | 104 | 113 | PF00069 | 0.397 |
DOC_MAPK_MEF2A_6 | 207 | 216 | PF00069 | 0.374 |
DOC_PP2B_LxvP_1 | 121 | 124 | PF13499 | 0.533 |
DOC_PP2B_LxvP_1 | 206 | 209 | PF13499 | 0.429 |
DOC_PP2B_LxvP_1 | 216 | 219 | PF13499 | 0.276 |
DOC_PP4_FxxP_1 | 361 | 364 | PF00568 | 0.524 |
DOC_USP7_MATH_1 | 405 | 409 | PF00917 | 0.738 |
DOC_USP7_UBL2_3 | 217 | 221 | PF12436 | 0.305 |
DOC_WW_Pin1_4 | 184 | 189 | PF00397 | 0.499 |
DOC_WW_Pin1_4 | 301 | 306 | PF00397 | 0.398 |
DOC_WW_Pin1_4 | 345 | 350 | PF00397 | 0.376 |
DOC_WW_Pin1_4 | 374 | 379 | PF00397 | 0.626 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.607 |
LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.446 |
LIG_Actin_WH2_2 | 286 | 304 | PF00022 | 0.465 |
LIG_Actin_WH2_2 | 322 | 340 | PF00022 | 0.286 |
LIG_APCC_ABBAyCdc20_2 | 106 | 112 | PF00400 | 0.352 |
LIG_EVH1_2 | 67 | 71 | PF00568 | 0.389 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.319 |
LIG_FHA_1 | 18 | 24 | PF00498 | 0.586 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.385 |
LIG_FHA_1 | 251 | 257 | PF00498 | 0.359 |
LIG_FHA_1 | 73 | 79 | PF00498 | 0.526 |
LIG_FHA_2 | 156 | 162 | PF00498 | 0.487 |
LIG_FHA_2 | 234 | 240 | PF00498 | 0.318 |
LIG_FHA_2 | 380 | 386 | PF00498 | 0.757 |
LIG_LIR_Apic_2 | 262 | 268 | PF02991 | 0.355 |
LIG_LIR_Apic_2 | 345 | 350 | PF02991 | 0.396 |
LIG_LIR_Gen_1 | 163 | 172 | PF02991 | 0.231 |
LIG_LIR_Gen_1 | 193 | 202 | PF02991 | 0.368 |
LIG_LIR_Gen_1 | 309 | 318 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 163 | 169 | PF02991 | 0.234 |
LIG_LIR_Nem_3 | 193 | 199 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 223 | 229 | PF02991 | 0.334 |
LIG_LIR_Nem_3 | 262 | 267 | PF02991 | 0.358 |
LIG_LIR_Nem_3 | 309 | 315 | PF02991 | 0.369 |
LIG_PCNA_yPIPBox_3 | 36 | 49 | PF02747 | 0.534 |
LIG_Pex14_1 | 222 | 226 | PF04695 | 0.342 |
LIG_PTB_Apo_2 | 257 | 264 | PF02174 | 0.446 |
LIG_SH2_CRK | 347 | 351 | PF00017 | 0.414 |
LIG_SH2_CRK | 352 | 356 | PF00017 | 0.439 |
LIG_SH2_NCK_1 | 130 | 134 | PF00017 | 0.354 |
LIG_SH2_NCK_1 | 347 | 351 | PF00017 | 0.359 |
LIG_SH2_PTP2 | 166 | 169 | PF00017 | 0.317 |
LIG_SH2_STAT3 | 278 | 281 | PF00017 | 0.510 |
LIG_SH2_STAT3 | 80 | 83 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.306 |
LIG_SH2_STAT5 | 166 | 169 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 271 | 274 | PF00017 | 0.294 |
LIG_SH2_STAT5 | 347 | 350 | PF00017 | 0.348 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.323 |
LIG_SH3_3 | 206 | 212 | PF00018 | 0.391 |
LIG_SH3_3 | 279 | 285 | PF00018 | 0.382 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.370 |
LIG_TYR_ITSM | 260 | 267 | PF00017 | 0.360 |
LIG_WW_1 | 349 | 352 | PF00397 | 0.389 |
MOD_CDK_SPK_2 | 184 | 189 | PF00069 | 0.484 |
MOD_CDK_SPxxK_3 | 51 | 58 | PF00069 | 0.602 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.747 |
MOD_CK1_1 | 376 | 382 | PF00069 | 0.752 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.316 |
MOD_CK2_1 | 379 | 385 | PF00069 | 0.670 |
MOD_DYRK1A_RPxSP_1 | 184 | 188 | PF00069 | 0.464 |
MOD_GlcNHglycan | 18 | 23 | PF01048 | 0.659 |
MOD_GlcNHglycan | 379 | 382 | PF01048 | 0.646 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.565 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.634 |
MOD_GSK3_1 | 373 | 380 | PF00069 | 0.703 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.676 |
MOD_N-GLC_1 | 405 | 410 | PF02516 | 0.514 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.312 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.483 |
MOD_NEK2_1 | 359 | 364 | PF00069 | 0.391 |
MOD_NEK2_1 | 43 | 48 | PF00069 | 0.679 |
MOD_NEK2_1 | 74 | 79 | PF00069 | 0.394 |
MOD_PIKK_1 | 350 | 356 | PF00454 | 0.592 |
MOD_PIKK_1 | 41 | 47 | PF00454 | 0.672 |
MOD_PKA_1 | 90 | 96 | PF00069 | 0.346 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.344 |
MOD_Plk_1 | 136 | 142 | PF00069 | 0.308 |
MOD_Plk_1 | 296 | 302 | PF00069 | 0.470 |
MOD_Plk_1 | 35 | 41 | PF00069 | 0.674 |
MOD_Plk_1 | 405 | 411 | PF00069 | 0.595 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.474 |
MOD_Plk_4 | 259 | 265 | PF00069 | 0.371 |
MOD_Plk_4 | 288 | 294 | PF00069 | 0.489 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.505 |
MOD_Plk_4 | 43 | 49 | PF00069 | 0.726 |
MOD_Plk_4 | 74 | 80 | PF00069 | 0.444 |
MOD_ProDKin_1 | 184 | 190 | PF00069 | 0.490 |
MOD_ProDKin_1 | 301 | 307 | PF00069 | 0.400 |
MOD_ProDKin_1 | 345 | 351 | PF00069 | 0.382 |
MOD_ProDKin_1 | 374 | 380 | PF00069 | 0.629 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.598 |
MOD_SUMO_rev_2 | 366 | 374 | PF00179 | 0.465 |
MOD_SUMO_rev_2 | 386 | 395 | PF00179 | 0.518 |
TRG_ENDOCYTIC_2 | 166 | 169 | PF00928 | 0.317 |
TRG_ENDOCYTIC_2 | 264 | 267 | PF00928 | 0.337 |
TRG_ENDOCYTIC_2 | 352 | 355 | PF00928 | 0.473 |
TRG_ER_diArg_1 | 172 | 174 | PF00400 | 0.375 |
TRG_ER_diArg_1 | 199 | 201 | PF00400 | 0.327 |
TRG_NES_CRM1_1 | 114 | 127 | PF08389 | 0.312 |
TRG_NES_CRM1_1 | 26 | 40 | PF08389 | 0.453 |
TRG_NES_CRM1_1 | 354 | 366 | PF08389 | 0.375 |
TRG_Pf-PMV_PEXEL_1 | 153 | 157 | PF00026 | 0.485 |
TRG_Pf-PMV_PEXEL_1 | 235 | 239 | PF00026 | 0.321 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBN5 | Leptomonas seymouri | 74% | 82% |
A0A0S4IUS1 | Bodo saltans | 56% | 100% |
A0A1X0NRZ1 | Trypanosomatidae | 58% | 100% |
A0A3Q8IH54 | Leishmania donovani | 85% | 100% |
A0A422N863 | Trypanosoma rangeli | 62% | 100% |
A4I866 | Leishmania infantum | 85% | 100% |
D0AAD4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 100% |
E9B324 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
Q4Q531 | Leishmania major | 87% | 100% |
V5BCX1 | Trypanosoma cruzi | 64% | 100% |